Clinical Trial 56356

Whittier, CA 90602


Summary:

<b>Osteoarthritis - Whittier CA</b>
Click image to enlarge

The ACTiVION-I study is an osteoarthritis (OA) clinical trial for adults over 40 years of age who have been diagnosed with OA in at least one knee. This study is seeking participants with knee pain caused  by primary OA or “wear-and-tear” OA. The study will evaluate how well the investigational study therapy works as a potential treatment in decreasing knee pain and improving knee function in people who have mild to moderate OA of the knee.

If you qualify and choose to join the ACTiVION-I clinical trial, you may be compensated for your time and reimbursed for travel. Additionally, you will receive possible access to a new investigational therapy, study support and monitoring by a healthcare team, education about OA, and the opportunity to advance OA research, all at no cost.


Who can join the ACTiVION-I clinical trial?

If you are experiencing knee and joint pain due to osteoarthritis, you may be able to join the ACTiVION-I clinical trial if you meet the following requirements:

  • Must be 40 years of age or older
  • Must have mild to moderate osteoarthritis that has been diagnosed in at least one knee (target knee)
  • You will be asked to rate your pain, mobility, and other symptoms during screening
  • Must not have pain so severe that it requires the use of a crutch, cane, prosthetic leg, or walker
  • Must not have had surgery on the target knee within the last six months or you are not planning or have scheduled total knee replacement surgery in the next 12 months
  • Have not had a major injury to the target knee within 12 months prior to screening

* Other study requirements will apply


Qualified Participants May Receive:

- Study related medical care at no charge

- Study medication at no charge

- May be eligible to receive time and travel compensation up to $800

- Diagnostic tests (X-ray, MRI) at no charge

Participants will be randomized at a 2:1 ratio, where:

  • 2 out of every 3 participants will receive the study therapy (TG-C)
  • 1 out of every 3 will receive a placebo (no active ingredients)


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.